Activity of the hypothalamic - Pituitary - Adrenal axis in multiple sclerosis: Correlations with gadolinium-enhancing lesions and ventricular volume

Annals of Neurology

Volumn 51, Issue 6, 2002, Pages 763-767

  Schumann, Erina M ^a   Kümpfel, Tania ^a   Bergh, Florian Then ^a   Trenkwalder, Claudia ^a   Holsboer, Florian ^a   Auer, Dorothee P ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; DEXAMETHASONE; GADOLINIUM; HYDROCORTISONE;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; BRAIN SIZE; BRAIN VENTRICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AREA UNDER CURVE; ATROPHY; BRAIN; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; FEMALE; GADOLINIUM; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PITUITARY-ADRENAL SYSTEM; STATISTICS;

EID: 0036266996     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10187     Document Type: Article

References (23)

1. Immune-neuro-endocrine interactions: Facts and hypotheses
2. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat
3. Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids
4. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids
5. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
6. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis
7. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect
8. Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis
9. Stereological estimation of the total volume of MR visible brain lesions in patients with multiple sclerosis
10. Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: A critical role for the hypothalamic-pituitary-adrenal axis
11. Susceptibility and resistance to experimental allergic encephalomyelitis: Relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat
12. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS
13. The neuroendocrine axis in patients with multiple sclerosis
14. Soluble E-selectin in multiple sclerosis: Raised concentrations in patients with primary progressive disease
15. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis
16. Dysregulation of the hypothalamo - Pituitary - Adrenal axis is related to the clinical course of MS
17. Axonal transection in the lesions of multiple sclerosis
18. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress
19. 3D MRI studies of neuroanatomic changes in unipolar major depression: The role of stress and medical comorbidity
20. Steroid effects on central neurons and implications for psychiatric and neurological disorders
21. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
22. A longitudinal study of brain atrophy in relapsing multiple sclerosis
23. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions